Review





Similar Products

96
PackGene Biotech lnc aav 2 0
Aav 2 0, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV2+Vector+Production/pm42637959-331-9-14
Average 96 stars, based on 1 article reviews
aav 2 0 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc viral vectors aav php eb hotofa1667d
Viral Vectors Aav Php Eb Hotofa1667d, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/pm42843343-313-108-111
Average 96 stars, based on 1 article reviews
viral vectors aav php eb hotofa1667d - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc aav php eb hsyn flag asxl3 n intein n
( A ) Illustration of the molecular strategy for the expression of the intact <t>ASXL3</t> protein facilitated by the Cfa GEP split intein. ( B ) Diagrammatic depiction of the retro-orbital injection technique applied to neonatal mice at postnatal day 3. Created in BioRender. Weng, W. (2026) https://BioRender.com/znoeri1 . ( C and D ) Immunodetection and quantitative analysis of total ASXL3 protein expression levels. AAV-GFP, injection of AAV-PHP.eB encoding GFP. AAV-Asxl3, injection of AAV-PHP.eB encoding Flag-ASXL3 N -Intein N and Intein C -ASXL3 C -HA. ( E to H ) Representative images and quantification of ASXL3 and PV expression in the RSC following AAV delivery. ( I to K ) Examination and quantification of ASXL3 and PV expression in the hippocampus after AAV administration. ( L and M ) Immunofluorescence staining of neurons in the second and third cortical layers, accompanied by quantitative analysis of neuronal counts. ( N and O ) Immunofluorescence staining of the fifth layer of cortical neurons and its number statistics. Data are presented as mean ± SEM, n = 3 mice per group. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test, with significance denoted by * P < 0.05, ** P < 0.01, *** P < 0.001.
Aav Php Eb Hsyn Flag Asxl3 N Intein N, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/pmc13600155-293-1-17
Average 96 stars, based on 1 article reviews
aav php eb hsyn flag asxl3 n intein n - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc aav php eb virus
a <t>AAV-PHP.eB-based</t> transgene delivery strategy involving retro-orbital injection in mice. EGFP-tagged SARS-CoV-2 ORF3a and EGFP were driven by a CAG promoter. b – d SARS-CoV-2 ORF3a expression leads to weight loss and mortality in mice. The wild-type mice were injected with AAV-PHP.eB at postnatal day 22 (P22) and weighed at P40 ( b ). The mice were sacrificed when substantial weight loss ( c ) and movement impairment ( d ) were observed. The dose of AAV-PHP. eB, 1 × 10 11 vg/20 g mice. e, f SARS-CoV-2 ORF3a interacts with endogenous CLCC1 and induces LC3 lipidation, ER-phagy, nucleophagy, and apoptosis in mouse brains. Four mice were sacrificed 28 days post AAV-PHP.eB injection. Brain lysates were prepared for co-IP experiments ( e ) and immunoblot analysis ( f ). In e , GFP-trap beads captured the EGFP-tagged SARS-CoV-2 ORF3a and EGFP. Red arrows indicate EGFP-tagged SARS-CoV-2 ORF3a as input. The relative expression level of endogenous CLCC1 was calculated and normalized ( e ). In f , antibodies against LC3, FAM134B, LMNB1, and caspase-3 were used to detect LC3-I/LC3-II conversion, ER-phagy, nucleophagy, and caspase-3-dependent apoptosis, respectively. g TEM images of hippocampal regions expressing SARS-CoV-2 ORF3a-EGFP or EGFP. Red arrow, the bleb amid NE; red asterisk, the autolysosome; blue arrow, ER whorl-like membrane stacks. N nucleus, M mitochondria, NE nuclear envelope, G Golgi apparatus; E endoplasmic reticulum, L lysosome. h , i Immunofluorescence analysis of mouse brains expressing SARS-CoV-2 ORF3a-EGFP and EGFP. The mice were sacrificed 20 days post AAV-PHP.eB administration. ER stress, misfolded protein accumulation, and protein degradation were assessed using staining for Bip, ubiquitin, and K48-linked ubiquitin, respectively, in the dentate gyrus and olfactory bulbs. j TUNEL assay of the hippocampal dentate gyrus in mice expressing SARS-CoV-2 ORF3a-EGFP vs EGFP control. k Neuroinflammatory profiling in thalamic regions of ORF3a-EGFP-expressing mice. Microglial activation (Iba1) and astrogliosis (GFAP) were assessed by immunostaining. Scale bar, 200 nm in g ; 5 μm in h and i ; 20 μm in j ; 50 μm in k . In b – d , n = 5. The values are presented as the mean ± SD. ** P < 0.01, by Student’s t -test ( c ) and the Mantel‒Cox test ( d ).
Aav Php Eb Virus, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/pmc13575168-646-0-17
Average 96 stars, based on 1 article reviews
aav php eb virus - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc aav php eb capsid
a <t>AAV-PHP.eB-based</t> transgene delivery strategy involving retro-orbital injection in mice. EGFP-tagged SARS-CoV-2 ORF3a and EGFP were driven by a CAG promoter. b – d SARS-CoV-2 ORF3a expression leads to weight loss and mortality in mice. The wild-type mice were injected with AAV-PHP.eB at postnatal day 22 (P22) and weighed at P40 ( b ). The mice were sacrificed when substantial weight loss ( c ) and movement impairment ( d ) were observed. The dose of AAV-PHP. eB, 1 × 10 11 vg/20 g mice. e, f SARS-CoV-2 ORF3a interacts with endogenous CLCC1 and induces LC3 lipidation, ER-phagy, nucleophagy, and apoptosis in mouse brains. Four mice were sacrificed 28 days post AAV-PHP.eB injection. Brain lysates were prepared for co-IP experiments ( e ) and immunoblot analysis ( f ). In e , GFP-trap beads captured the EGFP-tagged SARS-CoV-2 ORF3a and EGFP. Red arrows indicate EGFP-tagged SARS-CoV-2 ORF3a as input. The relative expression level of endogenous CLCC1 was calculated and normalized ( e ). In f , antibodies against LC3, FAM134B, LMNB1, and caspase-3 were used to detect LC3-I/LC3-II conversion, ER-phagy, nucleophagy, and caspase-3-dependent apoptosis, respectively. g TEM images of hippocampal regions expressing SARS-CoV-2 ORF3a-EGFP or EGFP. Red arrow, the bleb amid NE; red asterisk, the autolysosome; blue arrow, ER whorl-like membrane stacks. N nucleus, M mitochondria, NE nuclear envelope, G Golgi apparatus; E endoplasmic reticulum, L lysosome. h , i Immunofluorescence analysis of mouse brains expressing SARS-CoV-2 ORF3a-EGFP and EGFP. The mice were sacrificed 20 days post AAV-PHP.eB administration. ER stress, misfolded protein accumulation, and protein degradation were assessed using staining for Bip, ubiquitin, and K48-linked ubiquitin, respectively, in the dentate gyrus and olfactory bulbs. j TUNEL assay of the hippocampal dentate gyrus in mice expressing SARS-CoV-2 ORF3a-EGFP vs EGFP control. k Neuroinflammatory profiling in thalamic regions of ORF3a-EGFP-expressing mice. Microglial activation (Iba1) and astrogliosis (GFAP) were assessed by immunostaining. Scale bar, 200 nm in g ; 5 μm in h and i ; 20 μm in j ; 50 μm in k . In b – d , n = 5. The values are presented as the mean ± SD. ** P < 0.01, by Student’s t -test ( c ) and the Mantel‒Cox test ( d ).
Aav Php Eb Capsid, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/bio_rxiv__64898__2026__08__14__744746-51-6-9
Average 96 stars, based on 1 article reviews
aav php eb capsid - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc aav php eb p ets ∗ fluc
Safety and efficacy of P ETS∗ -driven cell lysis (A) Dose-dependent activation of P ETS∗ by different ETS-related transcription factors (ETS TFs) and fusion gene products. HEK293 cells were co-transfected with a synthetic promoter containing 21 tandem GGAA repeats driving SEAP expression (pQL71; P ETS∗ -SEAP-pA) and different amounts of constitutive expression vectors for ETS TFs (ETV1, pQL89; ETV4, pQL88; ETS1, pYSJ24; ELF4, pYSJ37; ELF3, pQL126; ELF5, pYSJ7; EHF, pYSJ6; ETV5, pYSJ1; ETS2, pYSJ4; ERG, pQL91; ETV2, pYSJ17; ELK1, pYSJ15; ELK3, pYSJ5; FLI1, pQL49; SPI1, pYSJ21; SPIB, pYSJ26; and SPIC, pYSJ27), fusion gene products containing ETS TFs (EWS-FEV, pYSJ29; EWS-FLI1, pQL43; EWS-ERG, pQL97; EWS-ETV1, pQL105; and EWS-ETV4, pQL104), or ETS-unrelated fusion genes (PAX3-FOXO1, pQD321; PAX7-FOXO1, pQD301; BCR-ABL, pSL1014; and AML1-ETO, pQZ197). For phosphorylation-dependent ETS family members (e.g., pELK1), cells were co-transfected with a constitutive expression vector for human insulin receptor activating MAPK signaling (pIR) and stimulated with recombinant human insulin (10 μg/mL). SEAP levels in culture supernatants were scored at 24 h post transfection. Data are presented as means ± SD; n = 3 individual experiments. Heatmap shows average log 2 -fold changes (log 2 FC) of SEAP expression for each condition divided by basal SEAP expression levels in non-transfected HEK293 cells. (B) ETS∗ specificity of the therapeutic gene circuit. Human lung adenocarcinoma (A549, NCI-H1299), adriamycin-resistant breast cancer (MCF7/ADR), colorectal cancer (LoVo), renal clear cell carcinoma (786-0), rhabdomyosarcoma (RD), breast adenocarcinoma (MCF-7), cervical cancer (HeLa), and native HEK293 cells were transduced with lentiviral particles created for P hCMV -, P ETS∗ -specific, or P hCMVmin -driven mCherry expression. Flow cytometry analysis (5 × 10 3 cells per group; gating threshold: 10 3 fluorescence units) was performed at 48 h after transduction. Expression of mCherry (data shown in B) and abnormal ETS TFs (data shown in A) was confirmed by quantitative reverse-transcription PCR (RT-qPCR) analysis. (C) Inactivity of P ETS∗ in healthy tissues in vivo . Constitutive (P hCMV -driven), abnormal ETS TF-selective (P ETS∗ -driven), and transcriptionally inactive (P hCMVmin -driven) expression units for firefly luciferase (FLuc) were transferred into AAV particles of the serotypes 2/9 and PHP.eB. Two weeks after intravenous injection of 1 × 10 11 vg AAV particles into healthy C57BL/6 mice, FLuc levels in different tissues (H, heart; Li, liver; Sp, spleen; Lu, lung; Ki, kidney; Br, brain) were recorded by bioluminescence imaging. AAV particles containing P MusAFP - or P <t>hGfaABC1D</t> -driven constructs with known tumor specificity were used as references. Data are shown as the mean ± SEM of n = 4 mice per group. Raw data showing whole-body distribution and normalized luminescence signals in all mice are shown in E. (D) Comparative analysis of different P ETS∗ -inducible cell-killing strategies. 48 h after transduction of A549 cells with lentivirus particles created for P ETS∗ -specific expression of the adenovirus replication gene (E1A), the ganciclovir-inducible suicide gene (HSV-TK), or the pro-apoptotic gene hBax, cells were supplemented with replication-deficient adenoviruses (AD ΔE1A , 5 MOI) or ganciclovir (GCV, 10 μM). Viability of cells was estimated using the CCK8 assay and by crystal violet staining after another 48 h. Data are presented as means ± SD; n = 3 individual experiments. ∗∗, p < 0.01; ∗∗∗∗, p < 0.0001. (E) P ETS∗ remains inactive in normal proliferating tissues. 5 days after establishing an excisional wound healing model in mice, 5 μg of plasmid DNA containing P hSurv -, P hE2F -, or P ETS∗ -driven mCherry expression units were intradermally injected into scar tissues. A P hCMV -driven expression vector was used as positive control for constitutive expression. A P hCMVmin -driven vector was used as negative control indicative for basal expression. Microscopic analysis of DAPI-stained skin tissues (scale bars, 200 μm) was performed at 48 h post transfection. Representative images for n = 3 mice are shown.
Aav Php Eb P Ets ∗ Fluc, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/pmc13522797-460-12-28
Average 96 stars, based on 1 article reviews
aav php eb p ets ∗ fluc - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc aav serotype 9 aav9 vectors
Safety and efficacy of P ETS∗ -driven cell lysis (A) Dose-dependent activation of P ETS∗ by different ETS-related transcription factors (ETS TFs) and fusion gene products. HEK293 cells were co-transfected with a synthetic promoter containing 21 tandem GGAA repeats driving SEAP expression (pQL71; P ETS∗ -SEAP-pA) and different amounts of constitutive expression vectors for ETS TFs (ETV1, pQL89; ETV4, pQL88; ETS1, pYSJ24; ELF4, pYSJ37; ELF3, pQL126; ELF5, pYSJ7; EHF, pYSJ6; ETV5, pYSJ1; ETS2, pYSJ4; ERG, pQL91; ETV2, pYSJ17; ELK1, pYSJ15; ELK3, pYSJ5; FLI1, pQL49; SPI1, pYSJ21; SPIB, pYSJ26; and SPIC, pYSJ27), fusion gene products containing ETS TFs (EWS-FEV, pYSJ29; EWS-FLI1, pQL43; EWS-ERG, pQL97; EWS-ETV1, pQL105; and EWS-ETV4, pQL104), or ETS-unrelated fusion genes (PAX3-FOXO1, pQD321; PAX7-FOXO1, pQD301; BCR-ABL, pSL1014; and AML1-ETO, pQZ197). For phosphorylation-dependent ETS family members (e.g., pELK1), cells were co-transfected with a constitutive expression vector for human insulin receptor activating MAPK signaling (pIR) and stimulated with recombinant human insulin (10 μg/mL). SEAP levels in culture supernatants were scored at 24 h post transfection. Data are presented as means ± SD; n = 3 individual experiments. Heatmap shows average log 2 -fold changes (log 2 FC) of SEAP expression for each condition divided by basal SEAP expression levels in non-transfected HEK293 cells. (B) ETS∗ specificity of the therapeutic gene circuit. Human lung adenocarcinoma (A549, NCI-H1299), adriamycin-resistant breast cancer (MCF7/ADR), colorectal cancer (LoVo), renal clear cell carcinoma (786-0), rhabdomyosarcoma (RD), breast adenocarcinoma (MCF-7), cervical cancer (HeLa), and native HEK293 cells were transduced with lentiviral particles created for P hCMV -, P ETS∗ -specific, or P hCMVmin -driven mCherry expression. Flow cytometry analysis (5 × 10 3 cells per group; gating threshold: 10 3 fluorescence units) was performed at 48 h after transduction. Expression of mCherry (data shown in B) and abnormal ETS TFs (data shown in A) was confirmed by quantitative reverse-transcription PCR (RT-qPCR) analysis. (C) Inactivity of P ETS∗ in healthy tissues in vivo . Constitutive (P hCMV -driven), abnormal ETS TF-selective (P ETS∗ -driven), and transcriptionally inactive (P hCMVmin -driven) expression units for firefly luciferase (FLuc) were transferred into AAV particles of the serotypes 2/9 and PHP.eB. Two weeks after intravenous injection of 1 × 10 11 vg AAV particles into healthy C57BL/6 mice, FLuc levels in different tissues (H, heart; Li, liver; Sp, spleen; Lu, lung; Ki, kidney; Br, brain) were recorded by bioluminescence imaging. AAV particles containing P MusAFP - or P <t>hGfaABC1D</t> -driven constructs with known tumor specificity were used as references. Data are shown as the mean ± SEM of n = 4 mice per group. Raw data showing whole-body distribution and normalized luminescence signals in all mice are shown in E. (D) Comparative analysis of different P ETS∗ -inducible cell-killing strategies. 48 h after transduction of A549 cells with lentivirus particles created for P ETS∗ -specific expression of the adenovirus replication gene (E1A), the ganciclovir-inducible suicide gene (HSV-TK), or the pro-apoptotic gene hBax, cells were supplemented with replication-deficient adenoviruses (AD ΔE1A , 5 MOI) or ganciclovir (GCV, 10 μM). Viability of cells was estimated using the CCK8 assay and by crystal violet staining after another 48 h. Data are presented as means ± SD; n = 3 individual experiments. ∗∗, p < 0.01; ∗∗∗∗, p < 0.0001. (E) P ETS∗ remains inactive in normal proliferating tissues. 5 days after establishing an excisional wound healing model in mice, 5 μg of plasmid DNA containing P hSurv -, P hE2F -, or P ETS∗ -driven mCherry expression units were intradermally injected into scar tissues. A P hCMV -driven expression vector was used as positive control for constitutive expression. A P hCMVmin -driven vector was used as negative control indicative for basal expression. Microscopic analysis of DAPI-stained skin tissues (scale bars, 200 μm) was performed at 48 h post transfection. Representative images for n = 3 mice are shown.
Aav Serotype 9 Aav9 Vectors, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV9+Vector+Production/pmc13455517-39-0-21
Average 96 stars, based on 1 article reviews
aav serotype 9 aav9 vectors - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc injection aav php eb carrying itr cag egfp wpre ploya itr
Safety and efficacy of P ETS∗ -driven cell lysis (A) Dose-dependent activation of P ETS∗ by different ETS-related transcription factors (ETS TFs) and fusion gene products. HEK293 cells were co-transfected with a synthetic promoter containing 21 tandem GGAA repeats driving SEAP expression (pQL71; P ETS∗ -SEAP-pA) and different amounts of constitutive expression vectors for ETS TFs (ETV1, pQL89; ETV4, pQL88; ETS1, pYSJ24; ELF4, pYSJ37; ELF3, pQL126; ELF5, pYSJ7; EHF, pYSJ6; ETV5, pYSJ1; ETS2, pYSJ4; ERG, pQL91; ETV2, pYSJ17; ELK1, pYSJ15; ELK3, pYSJ5; FLI1, pQL49; SPI1, pYSJ21; SPIB, pYSJ26; and SPIC, pYSJ27), fusion gene products containing ETS TFs (EWS-FEV, pYSJ29; EWS-FLI1, pQL43; EWS-ERG, pQL97; EWS-ETV1, pQL105; and EWS-ETV4, pQL104), or ETS-unrelated fusion genes (PAX3-FOXO1, pQD321; PAX7-FOXO1, pQD301; BCR-ABL, pSL1014; and AML1-ETO, pQZ197). For phosphorylation-dependent ETS family members (e.g., pELK1), cells were co-transfected with a constitutive expression vector for human insulin receptor activating MAPK signaling (pIR) and stimulated with recombinant human insulin (10 μg/mL). SEAP levels in culture supernatants were scored at 24 h post transfection. Data are presented as means ± SD; n = 3 individual experiments. Heatmap shows average log 2 -fold changes (log 2 FC) of SEAP expression for each condition divided by basal SEAP expression levels in non-transfected HEK293 cells. (B) ETS∗ specificity of the therapeutic gene circuit. Human lung adenocarcinoma (A549, NCI-H1299), adriamycin-resistant breast cancer (MCF7/ADR), colorectal cancer (LoVo), renal clear cell carcinoma (786-0), rhabdomyosarcoma (RD), breast adenocarcinoma (MCF-7), cervical cancer (HeLa), and native HEK293 cells were transduced with lentiviral particles created for P hCMV -, P ETS∗ -specific, or P hCMVmin -driven mCherry expression. Flow cytometry analysis (5 × 10 3 cells per group; gating threshold: 10 3 fluorescence units) was performed at 48 h after transduction. Expression of mCherry (data shown in B) and abnormal ETS TFs (data shown in A) was confirmed by quantitative reverse-transcription PCR (RT-qPCR) analysis. (C) Inactivity of P ETS∗ in healthy tissues in vivo . Constitutive (P hCMV -driven), abnormal ETS TF-selective (P ETS∗ -driven), and transcriptionally inactive (P hCMVmin -driven) expression units for firefly luciferase (FLuc) were transferred into AAV particles of the serotypes 2/9 and PHP.eB. Two weeks after intravenous injection of 1 × 10 11 vg AAV particles into healthy C57BL/6 mice, FLuc levels in different tissues (H, heart; Li, liver; Sp, spleen; Lu, lung; Ki, kidney; Br, brain) were recorded by bioluminescence imaging. AAV particles containing P MusAFP - or P <t>hGfaABC1D</t> -driven constructs with known tumor specificity were used as references. Data are shown as the mean ± SEM of n = 4 mice per group. Raw data showing whole-body distribution and normalized luminescence signals in all mice are shown in E. (D) Comparative analysis of different P ETS∗ -inducible cell-killing strategies. 48 h after transduction of A549 cells with lentivirus particles created for P ETS∗ -specific expression of the adenovirus replication gene (E1A), the ganciclovir-inducible suicide gene (HSV-TK), or the pro-apoptotic gene hBax, cells were supplemented with replication-deficient adenoviruses (AD ΔE1A , 5 MOI) or ganciclovir (GCV, 10 μM). Viability of cells was estimated using the CCK8 assay and by crystal violet staining after another 48 h. Data are presented as means ± SD; n = 3 individual experiments. ∗∗, p < 0.01; ∗∗∗∗, p < 0.0001. (E) P ETS∗ remains inactive in normal proliferating tissues. 5 days after establishing an excisional wound healing model in mice, 5 μg of plasmid DNA containing P hSurv -, P hE2F -, or P ETS∗ -driven mCherry expression units were intradermally injected into scar tissues. A P hCMV -driven expression vector was used as positive control for constitutive expression. A P hCMVmin -driven vector was used as negative control indicative for basal expression. Microscopic analysis of DAPI-stained skin tissues (scale bars, 200 μm) was performed at 48 h post transfection. Representative images for n = 3 mice are shown.
Injection Aav Php Eb Carrying Itr Cag Egfp Wpre Ploya Itr, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/pm42487092-37-4-8
Average 96 stars, based on 1 article reviews
injection aav php eb carrying itr cag egfp wpre ploya itr - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc smn2 sgrna contained php eb aav particles
a <t>SMN2</t> locus DNA sequence with annotated PAM, protospacer, ZFP binding site, and the targeting base. Targeted nucleotide (A4) editing efficiencies at SMN2 exon 7 by dCas12f-ABE and zmBEs in 293XT cells were measured via HTS ( b ); bystander editing is shown in ( c ). Error bars indicate SD from five independent experiments. Statistical tests used Dunnett T3 tests after Welch and Brown-Forsythe ANOVA. d 293XT cells were transfected with dCas12f-ABE, with or without the indicated ZFP and matched sgRNA. SMN2 exon 7 inclusion was assessed by RT-PCR. Unedited cells served as a mock; GAPDH as an endogenous control. e Quantified SMN2 exon 7 inclusion from ( d ). Error bars represent SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. f The top 25 PLM-predicted ZFP variants were cloned into dCas12f-ABE. Resultant zmBEs were transfected into 293XT cells with the SMN2 sgRNA. T:A(6)>C:G substitutions were analyzed by HTS. Data represent three independent experiments. Color coding marks ZFP mutation positions; dashed line represents activity of zmBE with original ZFP. Bottom : Schematic of SMN2 -targeting ZFP. g sgRNAs with different scaffolds were co-transfected with zmBE 1 into 293XT cells. T:A(6)>C:G editing efficiencies were determined by HTS. Error bars indicate SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. h Schematic of AAV vector containing zmABE and SMN2 -targeting sgRNA. i Schematic illustrating AAV delivery into SMA mice via CSF and IV injection. j Righting reflex time of SMA mice on P12. AAV-zmABE: n = 15; mock (untreated SMA mice): n = 15. Lines denote medians; each dot represents one mouse. Statistics by Mann-Whitney test, two-sided. k SMA mouse survival curves (AAV-zmABE: n = 15; mock: n = 15). Medians are indicated. Statistical analysis by Mantel-Cox test, two-sided. l T:A(6)>C:G editing was quantified by HTS in GFP-positive spinal cord nuclei from AAV-zmABE-treated SMA mice ( n = 5). Mock: untreated SMA mice ( n = 10). Each dot denotes one animal. Dashed and dotted lines indicate medians and quartiles, respectively. Statistical analysis by Mann-Whitney test, two-sided. Source data are provided as a Source Data file.
Smn2 Sgrna Contained Php Eb Aav Particles, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-PHP%2EeB+Vector+Production/pmc13500529-429-2-22
Average 96 stars, based on 1 article reviews
smn2 sgrna contained php eb aav particles - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
PackGene Biotech lnc anc80l65 cmv
a <t>SMN2</t> locus DNA sequence with annotated PAM, protospacer, ZFP binding site, and the targeting base. Targeted nucleotide (A4) editing efficiencies at SMN2 exon 7 by dCas12f-ABE and zmBEs in 293XT cells were measured via HTS ( b ); bystander editing is shown in ( c ). Error bars indicate SD from five independent experiments. Statistical tests used Dunnett T3 tests after Welch and Brown-Forsythe ANOVA. d 293XT cells were transfected with dCas12f-ABE, with or without the indicated ZFP and matched sgRNA. SMN2 exon 7 inclusion was assessed by RT-PCR. Unedited cells served as a mock; GAPDH as an endogenous control. e Quantified SMN2 exon 7 inclusion from ( d ). Error bars represent SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. f The top 25 PLM-predicted ZFP variants were cloned into dCas12f-ABE. Resultant zmBEs were transfected into 293XT cells with the SMN2 sgRNA. T:A(6)>C:G substitutions were analyzed by HTS. Data represent three independent experiments. Color coding marks ZFP mutation positions; dashed line represents activity of zmBE with original ZFP. Bottom : Schematic of SMN2 -targeting ZFP. g sgRNAs with different scaffolds were co-transfected with zmBE 1 into 293XT cells. T:A(6)>C:G editing efficiencies were determined by HTS. Error bars indicate SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. h Schematic of AAV vector containing zmABE and SMN2 -targeting sgRNA. i Schematic illustrating AAV delivery into SMA mice via CSF and IV injection. j Righting reflex time of SMA mice on P12. AAV-zmABE: n = 15; mock (untreated SMA mice): n = 15. Lines denote medians; each dot represents one mouse. Statistics by Mann-Whitney test, two-sided. k SMA mouse survival curves (AAV-zmABE: n = 15; mock: n = 15). Medians are indicated. Statistical analysis by Mantel-Cox test, two-sided. l T:A(6)>C:G editing was quantified by HTS in GFP-positive spinal cord nuclei from AAV-zmABE-treated SMA mice ( n = 5). Mock: untreated SMA mice ( n = 10). Each dot denotes one animal. Dashed and dotted lines indicate medians and quartiles, respectively. Statistical analysis by Mann-Whitney test, two-sided. Source data are provided as a Source Data file.
Anc80l65 Cmv, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aavs+production/AAV-Anc80+Vector+Production/pm42478043-190-2-8
Average 96 stars, based on 1 article reviews
anc80l65 cmv - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


( A ) Illustration of the molecular strategy for the expression of the intact ASXL3 protein facilitated by the Cfa GEP split intein. ( B ) Diagrammatic depiction of the retro-orbital injection technique applied to neonatal mice at postnatal day 3. Created in BioRender. Weng, W. (2026) https://BioRender.com/znoeri1 . ( C and D ) Immunodetection and quantitative analysis of total ASXL3 protein expression levels. AAV-GFP, injection of AAV-PHP.eB encoding GFP. AAV-Asxl3, injection of AAV-PHP.eB encoding Flag-ASXL3 N -Intein N and Intein C -ASXL3 C -HA. ( E to H ) Representative images and quantification of ASXL3 and PV expression in the RSC following AAV delivery. ( I to K ) Examination and quantification of ASXL3 and PV expression in the hippocampus after AAV administration. ( L and M ) Immunofluorescence staining of neurons in the second and third cortical layers, accompanied by quantitative analysis of neuronal counts. ( N and O ) Immunofluorescence staining of the fifth layer of cortical neurons and its number statistics. Data are presented as mean ± SEM, n = 3 mice per group. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test, with significance denoted by * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: Science Advances

Article Title: An ASXL3–thyroid hormone axis in parvalbumin interneurons controls autism-like behaviors

doi: 10.1126/sciadv.aeh2640

Figure Lengend Snippet: ( A ) Illustration of the molecular strategy for the expression of the intact ASXL3 protein facilitated by the Cfa GEP split intein. ( B ) Diagrammatic depiction of the retro-orbital injection technique applied to neonatal mice at postnatal day 3. Created in BioRender. Weng, W. (2026) https://BioRender.com/znoeri1 . ( C and D ) Immunodetection and quantitative analysis of total ASXL3 protein expression levels. AAV-GFP, injection of AAV-PHP.eB encoding GFP. AAV-Asxl3, injection of AAV-PHP.eB encoding Flag-ASXL3 N -Intein N and Intein C -ASXL3 C -HA. ( E to H ) Representative images and quantification of ASXL3 and PV expression in the RSC following AAV delivery. ( I to K ) Examination and quantification of ASXL3 and PV expression in the hippocampus after AAV administration. ( L and M ) Immunofluorescence staining of neurons in the second and third cortical layers, accompanied by quantitative analysis of neuronal counts. ( N and O ) Immunofluorescence staining of the fifth layer of cortical neurons and its number statistics. Data are presented as mean ± SEM, n = 3 mice per group. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test, with significance denoted by * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: The AAV-PHP.eB-hSyn-Flag-Asxl3 N -Intein N , AAV-PHP.eB-hSyn-Intein C -Asxl3 C - 3HA, and AAV-PHP.eB-hSyn-EGFP were procured from PackGene Biotech for retro-orbital injection.

Techniques: Expressing, Injection, Immunodetection, Analysis, Immunofluorescence, Staining

a AAV-PHP.eB-based transgene delivery strategy involving retro-orbital injection in mice. EGFP-tagged SARS-CoV-2 ORF3a and EGFP were driven by a CAG promoter. b – d SARS-CoV-2 ORF3a expression leads to weight loss and mortality in mice. The wild-type mice were injected with AAV-PHP.eB at postnatal day 22 (P22) and weighed at P40 ( b ). The mice were sacrificed when substantial weight loss ( c ) and movement impairment ( d ) were observed. The dose of AAV-PHP. eB, 1 × 10 11 vg/20 g mice. e, f SARS-CoV-2 ORF3a interacts with endogenous CLCC1 and induces LC3 lipidation, ER-phagy, nucleophagy, and apoptosis in mouse brains. Four mice were sacrificed 28 days post AAV-PHP.eB injection. Brain lysates were prepared for co-IP experiments ( e ) and immunoblot analysis ( f ). In e , GFP-trap beads captured the EGFP-tagged SARS-CoV-2 ORF3a and EGFP. Red arrows indicate EGFP-tagged SARS-CoV-2 ORF3a as input. The relative expression level of endogenous CLCC1 was calculated and normalized ( e ). In f , antibodies against LC3, FAM134B, LMNB1, and caspase-3 were used to detect LC3-I/LC3-II conversion, ER-phagy, nucleophagy, and caspase-3-dependent apoptosis, respectively. g TEM images of hippocampal regions expressing SARS-CoV-2 ORF3a-EGFP or EGFP. Red arrow, the bleb amid NE; red asterisk, the autolysosome; blue arrow, ER whorl-like membrane stacks. N nucleus, M mitochondria, NE nuclear envelope, G Golgi apparatus; E endoplasmic reticulum, L lysosome. h , i Immunofluorescence analysis of mouse brains expressing SARS-CoV-2 ORF3a-EGFP and EGFP. The mice were sacrificed 20 days post AAV-PHP.eB administration. ER stress, misfolded protein accumulation, and protein degradation were assessed using staining for Bip, ubiquitin, and K48-linked ubiquitin, respectively, in the dentate gyrus and olfactory bulbs. j TUNEL assay of the hippocampal dentate gyrus in mice expressing SARS-CoV-2 ORF3a-EGFP vs EGFP control. k Neuroinflammatory profiling in thalamic regions of ORF3a-EGFP-expressing mice. Microglial activation (Iba1) and astrogliosis (GFAP) were assessed by immunostaining. Scale bar, 200 nm in g ; 5 μm in h and i ; 20 μm in j ; 50 μm in k . In b – d , n = 5. The values are presented as the mean ± SD. ** P < 0.01, by Student’s t -test ( c ) and the Mantel‒Cox test ( d ).

Journal: Cell Discovery

Article Title: The accessory protein ORF3a hijacks the CLCC1 chloride channel to disrupt ER homeostasis in betacoronavirus pathogenesis

doi: 10.1038/s41421-026-00918-0

Figure Lengend Snippet: a AAV-PHP.eB-based transgene delivery strategy involving retro-orbital injection in mice. EGFP-tagged SARS-CoV-2 ORF3a and EGFP were driven by a CAG promoter. b – d SARS-CoV-2 ORF3a expression leads to weight loss and mortality in mice. The wild-type mice were injected with AAV-PHP.eB at postnatal day 22 (P22) and weighed at P40 ( b ). The mice were sacrificed when substantial weight loss ( c ) and movement impairment ( d ) were observed. The dose of AAV-PHP. eB, 1 × 10 11 vg/20 g mice. e, f SARS-CoV-2 ORF3a interacts with endogenous CLCC1 and induces LC3 lipidation, ER-phagy, nucleophagy, and apoptosis in mouse brains. Four mice were sacrificed 28 days post AAV-PHP.eB injection. Brain lysates were prepared for co-IP experiments ( e ) and immunoblot analysis ( f ). In e , GFP-trap beads captured the EGFP-tagged SARS-CoV-2 ORF3a and EGFP. Red arrows indicate EGFP-tagged SARS-CoV-2 ORF3a as input. The relative expression level of endogenous CLCC1 was calculated and normalized ( e ). In f , antibodies against LC3, FAM134B, LMNB1, and caspase-3 were used to detect LC3-I/LC3-II conversion, ER-phagy, nucleophagy, and caspase-3-dependent apoptosis, respectively. g TEM images of hippocampal regions expressing SARS-CoV-2 ORF3a-EGFP or EGFP. Red arrow, the bleb amid NE; red asterisk, the autolysosome; blue arrow, ER whorl-like membrane stacks. N nucleus, M mitochondria, NE nuclear envelope, G Golgi apparatus; E endoplasmic reticulum, L lysosome. h , i Immunofluorescence analysis of mouse brains expressing SARS-CoV-2 ORF3a-EGFP and EGFP. The mice were sacrificed 20 days post AAV-PHP.eB administration. ER stress, misfolded protein accumulation, and protein degradation were assessed using staining for Bip, ubiquitin, and K48-linked ubiquitin, respectively, in the dentate gyrus and olfactory bulbs. j TUNEL assay of the hippocampal dentate gyrus in mice expressing SARS-CoV-2 ORF3a-EGFP vs EGFP control. k Neuroinflammatory profiling in thalamic regions of ORF3a-EGFP-expressing mice. Microglial activation (Iba1) and astrogliosis (GFAP) were assessed by immunostaining. Scale bar, 200 nm in g ; 5 μm in h and i ; 20 μm in j ; 50 μm in k . In b – d , n = 5. The values are presented as the mean ± SD. ** P < 0.01, by Student’s t -test ( c ) and the Mantel‒Cox test ( d ).

Article Snippet: AAV-PHP.eB virus harboring a GFP and SARS-CoV-2 ORF3a cassette (1 × 10 13 vg/mL) was generated by Packgene Biotech and diluted to a final concentration of 50 × 10 10 vg/600 μL in sterile PBS.

Techniques: Injection, Expressing, Co-Immunoprecipitation Assay, Western Blot, Membrane, Immunofluorescence, Staining, Ubiquitin Proteomics, Olfactory, TUNEL Assay, Control, Activation Assay, Immunostaining

Safety and efficacy of P ETS∗ -driven cell lysis (A) Dose-dependent activation of P ETS∗ by different ETS-related transcription factors (ETS TFs) and fusion gene products. HEK293 cells were co-transfected with a synthetic promoter containing 21 tandem GGAA repeats driving SEAP expression (pQL71; P ETS∗ -SEAP-pA) and different amounts of constitutive expression vectors for ETS TFs (ETV1, pQL89; ETV4, pQL88; ETS1, pYSJ24; ELF4, pYSJ37; ELF3, pQL126; ELF5, pYSJ7; EHF, pYSJ6; ETV5, pYSJ1; ETS2, pYSJ4; ERG, pQL91; ETV2, pYSJ17; ELK1, pYSJ15; ELK3, pYSJ5; FLI1, pQL49; SPI1, pYSJ21; SPIB, pYSJ26; and SPIC, pYSJ27), fusion gene products containing ETS TFs (EWS-FEV, pYSJ29; EWS-FLI1, pQL43; EWS-ERG, pQL97; EWS-ETV1, pQL105; and EWS-ETV4, pQL104), or ETS-unrelated fusion genes (PAX3-FOXO1, pQD321; PAX7-FOXO1, pQD301; BCR-ABL, pSL1014; and AML1-ETO, pQZ197). For phosphorylation-dependent ETS family members (e.g., pELK1), cells were co-transfected with a constitutive expression vector for human insulin receptor activating MAPK signaling (pIR) and stimulated with recombinant human insulin (10 μg/mL). SEAP levels in culture supernatants were scored at 24 h post transfection. Data are presented as means ± SD; n = 3 individual experiments. Heatmap shows average log 2 -fold changes (log 2 FC) of SEAP expression for each condition divided by basal SEAP expression levels in non-transfected HEK293 cells. (B) ETS∗ specificity of the therapeutic gene circuit. Human lung adenocarcinoma (A549, NCI-H1299), adriamycin-resistant breast cancer (MCF7/ADR), colorectal cancer (LoVo), renal clear cell carcinoma (786-0), rhabdomyosarcoma (RD), breast adenocarcinoma (MCF-7), cervical cancer (HeLa), and native HEK293 cells were transduced with lentiviral particles created for P hCMV -, P ETS∗ -specific, or P hCMVmin -driven mCherry expression. Flow cytometry analysis (5 × 10 3 cells per group; gating threshold: 10 3 fluorescence units) was performed at 48 h after transduction. Expression of mCherry (data shown in B) and abnormal ETS TFs (data shown in A) was confirmed by quantitative reverse-transcription PCR (RT-qPCR) analysis. (C) Inactivity of P ETS∗ in healthy tissues in vivo . Constitutive (P hCMV -driven), abnormal ETS TF-selective (P ETS∗ -driven), and transcriptionally inactive (P hCMVmin -driven) expression units for firefly luciferase (FLuc) were transferred into AAV particles of the serotypes 2/9 and PHP.eB. Two weeks after intravenous injection of 1 × 10 11 vg AAV particles into healthy C57BL/6 mice, FLuc levels in different tissues (H, heart; Li, liver; Sp, spleen; Lu, lung; Ki, kidney; Br, brain) were recorded by bioluminescence imaging. AAV particles containing P MusAFP - or P hGfaABC1D -driven constructs with known tumor specificity were used as references. Data are shown as the mean ± SEM of n = 4 mice per group. Raw data showing whole-body distribution and normalized luminescence signals in all mice are shown in E. (D) Comparative analysis of different P ETS∗ -inducible cell-killing strategies. 48 h after transduction of A549 cells with lentivirus particles created for P ETS∗ -specific expression of the adenovirus replication gene (E1A), the ganciclovir-inducible suicide gene (HSV-TK), or the pro-apoptotic gene hBax, cells were supplemented with replication-deficient adenoviruses (AD ΔE1A , 5 MOI) or ganciclovir (GCV, 10 μM). Viability of cells was estimated using the CCK8 assay and by crystal violet staining after another 48 h. Data are presented as means ± SD; n = 3 individual experiments. ∗∗, p < 0.01; ∗∗∗∗, p < 0.0001. (E) P ETS∗ remains inactive in normal proliferating tissues. 5 days after establishing an excisional wound healing model in mice, 5 μg of plasmid DNA containing P hSurv -, P hE2F -, or P ETS∗ -driven mCherry expression units were intradermally injected into scar tissues. A P hCMV -driven expression vector was used as positive control for constitutive expression. A P hCMVmin -driven vector was used as negative control indicative for basal expression. Microscopic analysis of DAPI-stained skin tissues (scale bars, 200 μm) was performed at 48 h post transfection. Representative images for n = 3 mice are shown.

Journal: Cell Reports Medicine

Article Title: Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit

doi: 10.1016/j.xcrm.2026.102936

Figure Lengend Snippet: Safety and efficacy of P ETS∗ -driven cell lysis (A) Dose-dependent activation of P ETS∗ by different ETS-related transcription factors (ETS TFs) and fusion gene products. HEK293 cells were co-transfected with a synthetic promoter containing 21 tandem GGAA repeats driving SEAP expression (pQL71; P ETS∗ -SEAP-pA) and different amounts of constitutive expression vectors for ETS TFs (ETV1, pQL89; ETV4, pQL88; ETS1, pYSJ24; ELF4, pYSJ37; ELF3, pQL126; ELF5, pYSJ7; EHF, pYSJ6; ETV5, pYSJ1; ETS2, pYSJ4; ERG, pQL91; ETV2, pYSJ17; ELK1, pYSJ15; ELK3, pYSJ5; FLI1, pQL49; SPI1, pYSJ21; SPIB, pYSJ26; and SPIC, pYSJ27), fusion gene products containing ETS TFs (EWS-FEV, pYSJ29; EWS-FLI1, pQL43; EWS-ERG, pQL97; EWS-ETV1, pQL105; and EWS-ETV4, pQL104), or ETS-unrelated fusion genes (PAX3-FOXO1, pQD321; PAX7-FOXO1, pQD301; BCR-ABL, pSL1014; and AML1-ETO, pQZ197). For phosphorylation-dependent ETS family members (e.g., pELK1), cells were co-transfected with a constitutive expression vector for human insulin receptor activating MAPK signaling (pIR) and stimulated with recombinant human insulin (10 μg/mL). SEAP levels in culture supernatants were scored at 24 h post transfection. Data are presented as means ± SD; n = 3 individual experiments. Heatmap shows average log 2 -fold changes (log 2 FC) of SEAP expression for each condition divided by basal SEAP expression levels in non-transfected HEK293 cells. (B) ETS∗ specificity of the therapeutic gene circuit. Human lung adenocarcinoma (A549, NCI-H1299), adriamycin-resistant breast cancer (MCF7/ADR), colorectal cancer (LoVo), renal clear cell carcinoma (786-0), rhabdomyosarcoma (RD), breast adenocarcinoma (MCF-7), cervical cancer (HeLa), and native HEK293 cells were transduced with lentiviral particles created for P hCMV -, P ETS∗ -specific, or P hCMVmin -driven mCherry expression. Flow cytometry analysis (5 × 10 3 cells per group; gating threshold: 10 3 fluorescence units) was performed at 48 h after transduction. Expression of mCherry (data shown in B) and abnormal ETS TFs (data shown in A) was confirmed by quantitative reverse-transcription PCR (RT-qPCR) analysis. (C) Inactivity of P ETS∗ in healthy tissues in vivo . Constitutive (P hCMV -driven), abnormal ETS TF-selective (P ETS∗ -driven), and transcriptionally inactive (P hCMVmin -driven) expression units for firefly luciferase (FLuc) were transferred into AAV particles of the serotypes 2/9 and PHP.eB. Two weeks after intravenous injection of 1 × 10 11 vg AAV particles into healthy C57BL/6 mice, FLuc levels in different tissues (H, heart; Li, liver; Sp, spleen; Lu, lung; Ki, kidney; Br, brain) were recorded by bioluminescence imaging. AAV particles containing P MusAFP - or P hGfaABC1D -driven constructs with known tumor specificity were used as references. Data are shown as the mean ± SEM of n = 4 mice per group. Raw data showing whole-body distribution and normalized luminescence signals in all mice are shown in E. (D) Comparative analysis of different P ETS∗ -inducible cell-killing strategies. 48 h after transduction of A549 cells with lentivirus particles created for P ETS∗ -specific expression of the adenovirus replication gene (E1A), the ganciclovir-inducible suicide gene (HSV-TK), or the pro-apoptotic gene hBax, cells were supplemented with replication-deficient adenoviruses (AD ΔE1A , 5 MOI) or ganciclovir (GCV, 10 μM). Viability of cells was estimated using the CCK8 assay and by crystal violet staining after another 48 h. Data are presented as means ± SD; n = 3 individual experiments. ∗∗, p < 0.01; ∗∗∗∗, p < 0.0001. (E) P ETS∗ remains inactive in normal proliferating tissues. 5 days after establishing an excisional wound healing model in mice, 5 μg of plasmid DNA containing P hSurv -, P hE2F -, or P ETS∗ -driven mCherry expression units were intradermally injected into scar tissues. A P hCMV -driven expression vector was used as positive control for constitutive expression. A P hCMVmin -driven vector was used as negative control indicative for basal expression. Microscopic analysis of DAPI-stained skin tissues (scale bars, 200 μm) was performed at 48 h post transfection. Representative images for n = 3 mice are shown.

Article Snippet: AAV2/9-P ETS∗ -FLuc, AAV2/9-P MusAFP -Fluc, AAV2/9-P hCMV -FLuc, AAV2/9-P hCMVmin -FLuc, AAV-PHP.eB-P ETS∗ -FLuc, AAV-PHP.eB-P hCMV -Fluc, AAV-PHP.eB-P hCMVmin -Fluc and AAV-PHP.eB-P hGfaABC1D -Fluc were produced by PackGene Biotech (Guangzhou, China) using the transfer plasmids pQL120, pQL90, pYW475, pQL121 and pYW470 , respectively.

Techniques: Lysis, Activation Assay, Transfection, Expressing, Phospho-proteomics, Plasmid Preparation, Recombinant, Transduction, Flow Cytometry, Fluorescence, Reverse Transcription, Quantitative RT-PCR, In Vivo, Luciferase, Injection, Imaging, Construct, CCK-8 Assay, Staining, Positive Control, Negative Control

a SMN2 locus DNA sequence with annotated PAM, protospacer, ZFP binding site, and the targeting base. Targeted nucleotide (A4) editing efficiencies at SMN2 exon 7 by dCas12f-ABE and zmBEs in 293XT cells were measured via HTS ( b ); bystander editing is shown in ( c ). Error bars indicate SD from five independent experiments. Statistical tests used Dunnett T3 tests after Welch and Brown-Forsythe ANOVA. d 293XT cells were transfected with dCas12f-ABE, with or without the indicated ZFP and matched sgRNA. SMN2 exon 7 inclusion was assessed by RT-PCR. Unedited cells served as a mock; GAPDH as an endogenous control. e Quantified SMN2 exon 7 inclusion from ( d ). Error bars represent SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. f The top 25 PLM-predicted ZFP variants were cloned into dCas12f-ABE. Resultant zmBEs were transfected into 293XT cells with the SMN2 sgRNA. T:A(6)>C:G substitutions were analyzed by HTS. Data represent three independent experiments. Color coding marks ZFP mutation positions; dashed line represents activity of zmBE with original ZFP. Bottom : Schematic of SMN2 -targeting ZFP. g sgRNAs with different scaffolds were co-transfected with zmBE 1 into 293XT cells. T:A(6)>C:G editing efficiencies were determined by HTS. Error bars indicate SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. h Schematic of AAV vector containing zmABE and SMN2 -targeting sgRNA. i Schematic illustrating AAV delivery into SMA mice via CSF and IV injection. j Righting reflex time of SMA mice on P12. AAV-zmABE: n = 15; mock (untreated SMA mice): n = 15. Lines denote medians; each dot represents one mouse. Statistics by Mann-Whitney test, two-sided. k SMA mouse survival curves (AAV-zmABE: n = 15; mock: n = 15). Medians are indicated. Statistical analysis by Mantel-Cox test, two-sided. l T:A(6)>C:G editing was quantified by HTS in GFP-positive spinal cord nuclei from AAV-zmABE-treated SMA mice ( n = 5). Mock: untreated SMA mice ( n = 10). Each dot denotes one animal. Dashed and dotted lines indicate medians and quartiles, respectively. Statistical analysis by Mann-Whitney test, two-sided. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Incorporating AI-optimized zinc finger proteins enhances the efficiencies and targeting ranges of miniature base editors

doi: 10.1038/s41467-026-75912-x

Figure Lengend Snippet: a SMN2 locus DNA sequence with annotated PAM, protospacer, ZFP binding site, and the targeting base. Targeted nucleotide (A4) editing efficiencies at SMN2 exon 7 by dCas12f-ABE and zmBEs in 293XT cells were measured via HTS ( b ); bystander editing is shown in ( c ). Error bars indicate SD from five independent experiments. Statistical tests used Dunnett T3 tests after Welch and Brown-Forsythe ANOVA. d 293XT cells were transfected with dCas12f-ABE, with or without the indicated ZFP and matched sgRNA. SMN2 exon 7 inclusion was assessed by RT-PCR. Unedited cells served as a mock; GAPDH as an endogenous control. e Quantified SMN2 exon 7 inclusion from ( d ). Error bars represent SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. f The top 25 PLM-predicted ZFP variants were cloned into dCas12f-ABE. Resultant zmBEs were transfected into 293XT cells with the SMN2 sgRNA. T:A(6)>C:G substitutions were analyzed by HTS. Data represent three independent experiments. Color coding marks ZFP mutation positions; dashed line represents activity of zmBE with original ZFP. Bottom : Schematic of SMN2 -targeting ZFP. g sgRNAs with different scaffolds were co-transfected with zmBE 1 into 293XT cells. T:A(6)>C:G editing efficiencies were determined by HTS. Error bars indicate SD from three independent experiments. Statistics used Tukey tests after ordinary one-way ANOVA. h Schematic of AAV vector containing zmABE and SMN2 -targeting sgRNA. i Schematic illustrating AAV delivery into SMA mice via CSF and IV injection. j Righting reflex time of SMA mice on P12. AAV-zmABE: n = 15; mock (untreated SMA mice): n = 15. Lines denote medians; each dot represents one mouse. Statistics by Mann-Whitney test, two-sided. k SMA mouse survival curves (AAV-zmABE: n = 15; mock: n = 15). Medians are indicated. Statistical analysis by Mantel-Cox test, two-sided. l T:A(6)>C:G editing was quantified by HTS in GFP-positive spinal cord nuclei from AAV-zmABE-treated SMA mice ( n = 5). Mock: untreated SMA mice ( n = 10). Each dot denotes one animal. Dashed and dotted lines indicate medians and quartiles, respectively. Statistical analysis by Mann-Whitney test, two-sided. Source data are provided as a Source Data file.

Article Snippet: ZmABE and SMN2 sgRNA contained PHP.eB AAV particles (1 × 1013 vg/mL; sequence was listed in Supplementary Data ) were produced by PackGene Biotech (China).

Techniques: Sequencing, Binding Assay, Transfection, Reverse Transcription Polymerase Chain Reaction, Control, Clone Assay, Mutagenesis, Activity Assay, Plasmid Preparation, IV Injection, MANN-WHITNEY